Taste Alterations Study for Chemotherapy Side Effects
This study is looking at ways to help people manage taste changes (taste alterations or TA) that can happen during chemotherapy. It's testing two nurse-led approaches: the "Taste Alteration Self-Assessment" and "Taste Alternation Self-Management." These involve using a special tool (Chemotherapy-induced Taste Alterations Scale or CiTAS) to assess taste changes and then teaching you how to choose ways to manage your symptoms. The study wants to see if these methods help reduce the severity of taste changes, maintain your body mass index (BMI), and ensure you're eating enough. You might be able to join if you have a common type of cancer, are starting your first cycle of chemotherapy, and can read and speak English. The study aims to enroll 400 participants, but its current status is unclear.
- Study design
- This interventional study will randomly assign clinics to either provide usual care or usual care with added strategies for taste alteration management. It aims to enroll 400 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your taste alteration severity, BMI, and dietary intake will be measured through study completion, which is an average of 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Taste Alterations Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Mary L Hook, PhD, RN · PRINCIPAL_INVESTIGATOR · Aurora Sinai Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Taste Alteration SeverityThrough study completion, an average of 6 months.
A single item question with ordinal rating will be used to confirm taste alterations and evaluate severity of TA (control) The CiTAS tool (18 item ordinal rating tool) will be used to confirm taste alterations and evaluate severity of TA (treatment)
- Body mass index (BMI)Through study completion, an average of 6 months.
BMI is measured to monitor for changes in weight relative to height; It is used to monitor for changes in weight that may indicate that patient is experiencing weight loss during chemotherapy treatment.
- Dietary intakeThrough study completion, an average of 6 months.
All patients will be asked to report number of meals/day, number of snacks/day, and number of supplements per day as an estimate of food intake during chemotherapy.